ALCOLADO RELAMPAGO topical liniment recalled for manufacturing process violations
Ecometics, Inc. is recalling ALCOLADO RELAMPAGO (menthol and camphor) topical liniment nationwide due to manufacturing process deviations. Products were not manufactured under current good manufacturing practices.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall based on manufacturing practice deviations. No illnesses, injuries, or deaths have been reported in the source material. The recall is precautionary in nature, triggered by CGMP violations rather than documented safety incidents.
Plain-English summary
Ecometics, Inc. is recalling ALCOLADO RELAMPAGO, a menthol and camphor topical liniment, due to manufacturing process deviations. The product was distributed nationwide in 7 fluid ounce (207 ml) and 16 fluid ounce (472 ml) bottle sizes by The Larkspur Group, Inc., Norwalk, Connecticut.
The products were not manufactured under current good manufacturing practices (CGMP). Current good manufacturing practices are FDA requirements that ensure products are produced with appropriate quality controls and procedures.
The recall includes multiple lot codes with expiration dates from October 2023 through May 2024. Consumers who have purchased this product should discontinue use immediately.
The recalled product
- Product
- ALCOLADO RELAMPAGO (Menthol and Camphor), 1% and 1.5% respectively, packaged in a 7 FLUID OZ (207 ml) bottles, UPC 7 18864 20102 9 and b) 16 FLUID OZ (472 ml) bottles, UPC 7 18864, 20110 4, Distributed by: The Larkspur Group, Inc., Norwalk, CT 06854.
- Manufacturer
- Ecometics, Inc.
- Category
- Drug — Topical Liniment
- Hazard
- manufacturing-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (9)
- a) 0E280A
- exp 10/23
- 0E318A
- exp 11/23
- 1E109A
- exp 3/24
- 1E141A
- exp 5/24
- b) 0E280A
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27